{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T04:11:25Z","timestamp":1795061485079,"version":"4.10.2"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:p>The distinction between choriocarcinoma and residual trophoblastic cell proliferation from a complete hydatidiform mole\/invasive mole (CHM\/IM) without villi is challenging on curettage materials. We investigated whether SALL4 immunostaining could help differentiate various gestational trophoblastic diseases. Placental site nodules (PSN; n=10), atypical PSN (APSN; n=8), placental site trophoblastic tumors (PSTT; n=9), epithelioid trophoblastic tumors (ETT; n=5), gestational choriocarcinomas (n=31), partial hydatidiform moles (PHM; n=13), CHM\/IM (n=47), and nonmolar products of conception (POC) (n=26) were included. SALL4 immunostaining was quantified (0 [1% to 10%], [11% to 100%]) and characterized (scattered single-cell or clustered nuclear positivity) in 2 locations: cytotrophoblast\/intermediate trophoblast and villous stromal fibroblasts. A diffuse (11% to 100%) and clustered pattern of SALL4 immunostaining in cytotrophoblast\/intermediate trophoblast was statistically associated with choriocarcinomas (74.2%, 23\/31) as compared with PSN (0\/10; <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.0001), APSN (0\/8; <jats:italic toggle=\"yes\">P<\/jats:italic>=0.0002), PSTT (0\/9; <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.0001), ETT (0\/5; <jats:italic toggle=\"yes\">P<\/jats:italic>=0.0034), PHM (0\/13; <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.0001), CHM\/IM (0\/47; <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.0001), and nonmolar POC (0\/26; <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.0001). Most nonchoriocarcinoma samples showed no SALL4 expression; when present, it was of low level (1% to 10%) and with a scattered single-cell staining in 3\/9 PSTT (33%), 1\/13 PHM (7.7%), 19\/47 CHM\/IM (40%), and 1\/26 nonmolar POC (1.7%). These results were confirmed using a validation cohort. In addition, 66% (31\/47) of CHM\/IM villous stromal fibroblasts showed SALL4 expression (11% to 100%) (all before 14 gestational weeks), whereas this level of expression was never observed in PHM (0\/13), nor in nonmolar POC (0\/26; <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.0001). Finally, a clustered and &gt;10% SALL4 immunostaining in cytotrophoblast\/intermediate trophoblast favors choriocarcinoma diagnosis. SALL4 expression in &gt;10% villous stromal fibroblasts before 14 gestational weeks favors CHM\/IM rather than PHM and nonmolar POC.<\/jats:p>","DOI":"10.1097\/pas.0000000000002358","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T06:01:00Z","timestamp":1738130460000},"page":"417-428","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["SALL4 as a Useful Marker for the Distinction of Various Gestational Trophoblastic Disease Subtypes"],"prefix":"10.1097","volume":"49","author":[{"given":"Alexis","family":"Trecourt","sequence":"first","affiliation":[{"name":"Service de Pathologie Multi-Site, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon"},{"name":"Centre pour l\u2019innovation en canc\u00e9rologie de Lyon (CICLY), Facult\u00e9 de M\u00e9decine Lyon Sud, Universit\u00e9 Claude Bernard Lyon-1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Donzel","sequence":"additional","affiliation":[{"name":"Service de Pathologie Multi-Site, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) U1111, Centre National de la Recherche Scientifique (CNRS), Universit\u00e9 Claude Bernard Lyon-1, Centre International de Recherche en Infectiologie (CIRI), UMR5308, Ecole Normale Sup\u00e9rieure de Lyon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Gaillot-Durand","sequence":"additional","affiliation":[{"name":"Service de Pathologie Multi-Site, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon"},{"name":"Centre Fran\u00e7ais de R\u00e9f\u00e9rence des maladies trophoblastique"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre A.","family":"Bolze","sequence":"additional","affiliation":[{"name":"Service de Chirurgie Gyn\u00e9cologique et Oncologique, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Universit\u00e9 Lyon 1, Obst\u00e9trique, CICLY, Pierre B\u00e9nite"},{"name":"Centre Fran\u00e7ais de R\u00e9f\u00e9rence des maladies trophoblastique"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Golfier","sequence":"additional","affiliation":[{"name":"Service de Chirurgie Gyn\u00e9cologique et Oncologique, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Universit\u00e9 Lyon 1, Obst\u00e9trique, CICLY, Pierre B\u00e9nite"},{"name":"Centre Fran\u00e7ais de R\u00e9f\u00e9rence des maladies trophoblastique"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Descargues","sequence":"additional","affiliation":[{"name":"Service de Chirurgie Gyn\u00e9cologique et Oncologique, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Universit\u00e9 Lyon 1, Obst\u00e9trique, CICLY, Pierre B\u00e9nite"},{"name":"Centre Fran\u00e7ais de R\u00e9f\u00e9rence des maladies trophoblastique"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Touria","family":"Hajri","sequence":"additional","affiliation":[{"name":"Centre Fran\u00e7ais de R\u00e9f\u00e9rence des maladies trophoblastique"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Mauduit","sequence":"additional","affiliation":[{"name":"Service de Pathologie Multi-Site, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon"},{"name":"Centre M\u00e9diterran\u00e9en de M\u00e9decine Mol\u00e9culaire (C3M), Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, Unit\u00e9 1065, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojgan","family":"Devouassoux-Shisheboran","sequence":"additional","affiliation":[{"name":"Service de Pathologie Multi-Site, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon"},{"name":"Centre pour l\u2019innovation en canc\u00e9rologie de Lyon (CICLY), Facult\u00e9 de M\u00e9decine Lyon Sud, Universit\u00e9 Claude Bernard Lyon-1"},{"name":"Centre Fran\u00e7ais de R\u00e9f\u00e9rence des maladies trophoblastique"},{"name":"Facult\u00e9 de M\u00e9decine Lyon Est, Universit\u00e9 Claude Bernard Lyon-1, Lyon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Allias","sequence":"additional","affiliation":[{"name":"Service de Pathologie Multi-Site, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon"},{"name":"Centre Fran\u00e7ais de R\u00e9f\u00e9rence des maladies trophoblastique"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"R1-20250416","doi-asserted-by":"crossref","first-page":"16410","DOI":"10.1038\/s41598-018-34745-5","article-title":"Temporal changes of Sall4 lineage contribution in developing embryos and the contribution of Sall4-lineages to postnatal germ cells in mice","volume":"8","author":"Tahara","year":"2018","journal-title":"Sci Rep"},{"key":"R2-20250416","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.stem.2008.08.004","article-title":"Sall4 regulates distinct transcription circuitries in different blastocyst-derived stem cell lineages","volume":"3","author":"Lim","year":"2008","journal-title":"Cell Stem Cell"},{"key":"R3-20250416","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/ncb1481","article-title":"Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1","volume":"8","author":"Zhang","year":"2006","journal-title":"Nat Cell Biol"},{"key":"R4-20250416","doi-asserted-by":"crossref","first-page":"5364","DOI":"10.1128\/MCB.00419-10","article-title":"Differential roles of Sall4 isoforms in embryonic stem cell pluripotency","volume":"30","author":"Rao","year":"2010","journal-title":"Mol Cell Biol"},{"key":"R5-20250416","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1365-2443.2009.01301.x","article-title":"Roles of Sall4 in the generation of pluripotent stem cells from blastocysts and fibroblasts","volume":"14","author":"Tsubooka","year":"2009","journal-title":"Genes Cells"},{"key":"R6-20250416","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.gene.2016.02.019","article-title":"SALL4, the missing link between stem cells, development and cancer","volume":"584","author":"Tatetsu","year":"2016","journal-title":"Gene"},{"key":"R7-20250416","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/PAS.0000000000000116","article-title":"SALL4 expression in germ cell and non-germ cell tumors: a systematic immunohistochemical study of 3215 cases","volume":"38","author":"Miettinen","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R8-20250416","doi-asserted-by":"crossref","first-page":"e24927","DOI":"10.1002\/jcla.24927","article-title":"The new advance of SALL4 in cancer: function, regulation, and implication","volume":"37","author":"Abouelnazar","year":"2023","journal-title":"J Clin Lab Anal"},{"key":"R9-20250416","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.3390\/biomedicines9101474","article-title":"Transcriptomic characterization of postmolar gestational choriocarcinoma","volume":"9","author":"Collet","year":"2021","journal-title":"Biomedicines"},{"key":"R10-20250416","doi-asserted-by":"crossref","first-page":"22968","DOI":"10.18632\/oncotarget.14952","article-title":"Oncofetal gene SALL4 and prognosis in cancer: a systematic review with meta-analysis","volume":"8","author":"Nicol\u00e8","year":"2017","journal-title":"Oncotarget"},{"key":"R11-20250416","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00383-020-04652-w","article-title":"SALL4 is a useful marker for pediatric yolk sac tumors","volume":"36","author":"Wu","year":"2020","journal-title":"Pediatr Surg Int"},{"key":"R12-20250416","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/PAS.0b013e318198177d","article-title":"SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma","volume":"33","author":"Cao","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R13-20250416","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1002\/cncr.24308","article-title":"SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors","volume":"115","author":"Cao","year":"2009","journal-title":"Cancer"},{"key":"R14-20250416","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/PAS.0b013e3181a13eef","article-title":"SALL4 is a novel diagnostic marker for testicular germ cell tumors","volume":"33","author":"Cao","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R15-20250416","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/PAS.0b013e3181ad25d5","article-title":"Diagnostic utility of SALL4 in extragonadal yolk sac tumors: an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3","volume":"33","author":"Wang","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R16-20250416","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/PAS.0b013e3181db84aa","article-title":"Diagnostic utility of novel stem cell markers SALL4, OCT4, NANOG, SOX2, UTF1, and TCL1 in primary mediastinal germ cell tumors","volume":"34","author":"Liu","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R17-20250416","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.humpath.2016.03.012","article-title":"SALL4 expression in gestational trophoblastic tumors: a useful tool to distinguish choriocarcinoma from placental site trophoblastic tumor and epithelioid trophoblastic tumor","volume":"54","author":"Stichelbout","year":"2016","journal-title":"Hum Pathol"},{"key":"R18-20250416","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4103\/ijpm.ijpm_212_22","article-title":"Epithelioid trophoblastic tumor: a case series","volume":"66","author":"Dash","year":"2023","journal-title":"Indian J Pathol Microbiol"},{"key":"R19-20250416","doi-asserted-by":"crossref","first-page":"e13233","DOI":"10.1111\/aji.13233","article-title":"Differential expression of SALL4 in CTCs derived from hydatidiform moles and gestational trophoblastic neoplasms","volume":"83","author":"Xu","year":"2020","journal-title":"Am J Reprod Immunol"},{"key":"R20-20250416","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5858\/arpa.2018-0234-RA","article-title":"Gestational trophoblastic tumors: a timely review of diagnostic pathology","volume":"143","author":"Hui","year":"2019","journal-title":"Arch Pathol Lab Med"},{"key":"R21-20250416","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mpdhp.2018.12.004","article-title":"Gestational trophoblastic tumours and non-neoplastic trophoblastic lesions: morphology and immunocytochemistry to refine the diagnosis","volume":"25","author":"Kaur","year":"2016","journal-title":"Diagnostic Histopathology"},{"issue":"suppl 1","key":"R22-20250416","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/ijgo.13877","article-title":"Diagnosis and management of gestational trophoblastic disease: 2021 update","volume":"155","author":"Ngan","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"R24-20250416","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00428-023-03658-8","article-title":"Practical guidelines of the EOTTD for pathological and genetic diagnosis of hydatidiform moles","volume":"484","author":"Bartosch","year":"2024","journal-title":"Virchows Arch"},{"key":"R25-20250416","doi-asserted-by":"crossref","first-page":"100046","DOI":"10.1016\/j.modpat.2022.100046","article-title":"Molecular analyses of chorionic-type intermediate trophoblastic lesions: atypical placental site nodules are closer to placental site nodules than epithelioid trophoblastic tumors","volume":"36","author":"Jeremie","year":"2023","journal-title":"Mod Pathol"},{"key":"R26-20250416","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.humpath.2020.04.011","article-title":"p57-discordant villi in hydropic products of conception: a clinicopathological study of 70 cases","volume":"101","author":"Gaillot-Durand","year":"2020","journal-title":"Hum Pathol"},{"key":"R27-20250416","doi-asserted-by":"crossref","first-page":"102704","DOI":"10.1016\/j.jogoh.2023.102704","article-title":"Impact of molecular genotyping on the diagnosis and treatment of human chorionic gonadotropin-producing tumors","volume":"53","author":"Peyle","year":"2024","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"R28-20250416","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/AOG.0000000000004240","article-title":"Gestational trophoblastic disease: current evaluation and management","volume":"137","author":"Soper","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R29-20250416","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/s41379-020-00691-9","article-title":"Refined diagnosis of hydatidiform moles with p57 immunohistochemistry and molecular genotyping: updated analysis of a prospective series of 2217 cases","volume":"34","author":"Xing","year":"2021","journal-title":"Mod Pathol"},{"key":"R30-20250416","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1566524023362960","article-title":"Molecular basis of gestational trophoblastic diseases","volume":"2","author":"Shih","year":"2002","journal-title":"Curr Mol Med"},{"key":"R31-20250416","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00004347-200101000-00004","article-title":"The pathology of intermediate trophoblastic tumors and tumor-like lesions","volume":"20","author":"Shih","year":"2001","journal-title":"Int J Gynecol Pathol"},{"key":"R32-20250416","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00018-022-04475-z","article-title":"How trophoblasts fuse: an in-depth look into placental syncytiotrophoblast formation","volume":"79","author":"Renaud","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"R33-20250416","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S1470-2045(07)70204-8","article-title":"Gestational trophoblastic neoplasia\u2014pathogenesis and potential therapeutic targets","volume":"8","author":"Shih","year":"2007","journal-title":"Lancet Oncol"},{"key":"R34-20250416","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/s41419-021-04315-1","article-title":"miR-497-5p\/SALL4 axis promotes stemness phenotype of choriocarcinoma and forms a feedback loop with DNMT-mediated epigenetic regulation","volume":"12","author":"Peng","year":"2021","journal-title":"Cell Death Dis"},{"key":"R35-20250416","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1056\/NEJMoa1300297","article-title":"Oncofetal gene SALL4 in aggressive hepatocellular carcinoma","volume":"368","author":"Yong","year":"2013","journal-title":"N Engl J Med"},{"key":"R36-20250416","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.3892\/or.2016.4545","article-title":"SALL4 is a marker of poor prognosis in serous ovarian carcinoma promoting invasion and metastasis","volume":"35","author":"Yang","year":"2016","journal-title":"Oncol Rep"},{"key":"R37-20250416","doi-asserted-by":"crossref","first-page":"13471","DOI":"10.1002\/cam4.5998","article-title":"SALL4 correlates with proliferation, metastasis, and poor prognosis in prostate cancer by affecting MAPK pathway","volume":"12","author":"Zhou","year":"2023","journal-title":"Cancer Med"},{"key":"R38-20250416","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1182\/blood-2007-11-126326","article-title":"SALL4 is a key regulator of survival and apoptosis in human leukemic cells","volume":"112","author":"Yang","year":"2008","journal-title":"Blood"},{"key":"R39-20250416","doi-asserted-by":"crossref","first-page":"27416","DOI":"10.18632\/oncotarget.4862","article-title":"SALL4 is a novel therapeutic target in intrahepatic cholangiocarcinoma","volume":"6","author":"Deng","year":"2015","journal-title":"Oncotarget"},{"key":"R40-20250416","doi-asserted-by":"crossref","first-page":"75425","DOI":"10.18632\/oncotarget.12251","article-title":"Targeting SALL4 by entinostat in lung cancer","volume":"7","author":"Yong","year":"2016","journal-title":"Oncotarget"},{"key":"R41-20250416","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0090-8258(84)90059-3","article-title":"Choriocarcinoma following term gestation","volume":"17","author":"Berkowitz","year":"1984","journal-title":"Gynecol Oncol"},{"key":"R43-20250416","first-page":"573","article-title":"Heterogeneity of mesenchymal cells in human amniotic membrane at term","volume":"39","author":"Cortes-Sandoval","year":"2024","journal-title":"Histol Histopathol"},{"key":"R44-20250416","doi-asserted-by":"crossref","first-page":"16319","DOI":"10.1073\/pnas.0607884103","article-title":"Murine inner cell mass-derived lineages depend on Sall4 function","volume":"103","author":"Elling","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"R45-20250416","first-page":"e920851","article-title":"Spalt-like protein 4 (SALL4) promotes angiogenesis by activating vascular endothelial growth factor A (VEGFA) signaling","volume":"26","author":"Sun","year":"2020","journal-title":"Med Sci Monit"},{"key":"R46-20250416","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jclinpath-2011-200191","article-title":"A placental chorionic villous mesenchymal core cellular origin for infantile haemangioma","volume":"64","author":"Itinteang","year":"2011","journal-title":"J Clin Pathol"},{"key":"R47-20250416","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fsurg.2014.00038","article-title":"Biology of infantile hemangioma","volume":"1","author":"Itinteang","year":"2014","journal-title":"Front Surg"},{"key":"R48-20250416","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/jclinpath-2011-200462","article-title":"Infantile haemangioma expresses embryonic stem cell markers","volume":"65","author":"Itinteang","year":"2012","journal-title":"J Clin Pathol"},{"key":"R49-20250416","doi-asserted-by":"crossref","first-page":"35811","DOI":"10.1038\/srep35811","article-title":"Infantile hemangioma originates from a dysregulated but not fully transformed multipotent stem cell","volume":"6","author":"Harbi","year":"2016","journal-title":"Sci Rep"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002358","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T14:00:44Z","timestamp":1744812044000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002358"}},"subtitle":["Choriocarcinoma From Other Trophoblastic Lesions and Early Complete Hydatidiform Mole From Partial Mole and NonMolar Villi"],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002358","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]}}}